Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion

Conclusion Treatment with zoledronic acid in osteoporotic patients with spinal fusion shortens the time to fusion, improves the fusion rate, prevents subsequent aVCFs, and improves clinical outcomes.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research